Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Diagnostic Microbiology and Infectious Disease
|
April 13, 2013
Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?
William Shomali, Ray Hachem, Anne-Marie Chaftari, et al.
Cancer
|
May 19, 2012
Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients?
William Shomali, Ray Hachem, Anne-Marie Chaftari, et al.
Blood Advances
|
September 8, 2021
A novel activating JAK1 mutation in chronic eosinophilic leukemia
William Shomali, Alisa Damnernsawad, Talent Theparee, et al.
Leukemia & Lymphoma
|
June 17, 2020
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience
Armon Azizi, Asiri Ediriwickrema, Ritika Dutta, et al.
NPJ Digital Medicine
|
August 19, 2025
Real time machine learning prediction of next generation sequencing test results in live clinical settings
Grace Y E Kim, Matthew Schwede, Conor K Corbin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2013
Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies
Munirah Al Shuaibi, Ramez R Bahu, Anne-Marie Chaftari, et al.
Critical Care Medicine
|
August 2, 2014
The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*
Labib Debiane, Ray Y Hachem, Iba Al Wohoush, et al.
British Journal of Haematology
|
June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations
Nicole Naumann, Johannes Lübke, William Shomali, et al.
Blood Advances
|
April 5, 2022
Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations
Haiyu Zhang, May Chien, Yu Hou, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
Jason Gotlib, Juliana Schwaab, William Shomali, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Diagnostic Microbiology and Infectious Disease
|
April 13, 2013
Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?
William Shomali, Ray Hachem, Anne-Marie Chaftari, et al.
Cancer
|
May 19, 2012
Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients?
William Shomali, Ray Hachem, Anne-Marie Chaftari, et al.
Blood Advances
|
September 8, 2021
A novel activating JAK1 mutation in chronic eosinophilic leukemia
William Shomali, Alisa Damnernsawad, Talent Theparee, et al.
Leukemia & Lymphoma
|
June 17, 2020
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience
Armon Azizi, Asiri Ediriwickrema, Ritika Dutta, et al.
NPJ Digital Medicine
|
August 19, 2025
Real time machine learning prediction of next generation sequencing test results in live clinical settings
Grace Y E Kim, Matthew Schwede, Conor K Corbin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2013
Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies
Munirah Al Shuaibi, Ramez R Bahu, Anne-Marie Chaftari, et al.
Critical Care Medicine
|
August 2, 2014
The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*
Labib Debiane, Ray Y Hachem, Iba Al Wohoush, et al.
British Journal of Haematology
|
June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations
Nicole Naumann, Johannes Lübke, William Shomali, et al.
Blood Advances
|
April 5, 2022
Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations
Haiyu Zhang, May Chien, Yu Hou, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
Jason Gotlib, Juliana Schwaab, William Shomali, et al.
Page
of 4